(Q39996855)

English

The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Jhao-Hao Hong

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Lyu-Han Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Yun-Wei Lin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

0 references

publication date

4 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

314

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1881-1891

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

The epidermal growth factor receptor as a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Epidermal growth factor receptor activation: how exon 19 and 21 mutations changed our understanding of the pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Role of the human RAD51 protein in homologous recombination and double-stranded-break repair

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

BRCA2-dependent and independent formation of RAD51 nuclear foci.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Organization and regulation of mitogen-activated protein kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

p38 MAP kinases: beyond the stress response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Mammalian MAP kinase signalling cascades

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Coordinating ERK/MAPK signalling through scaffolds and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: involvement of two excision repair mechanisms in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

p53 mutations, benzo[a]pyrene and lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Fifty years of benzo(a)pyrene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Chemical and mutagenic specificities of polycyclic aromatic hydrocarbon carcinogens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

DNA adducts of chemical carcinogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Induction of cell death, DNA strand breaks, and cell cycle arrest in DU145 human prostate carcinoma cell line by benzo[a]pyrene and benzo[a]pyrene-7,8-diol-9,10-epoxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

PYK2 mediates anti-apoptotic AKT signaling in response to benzo[a]pyrene diol epoxide in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NFkappaB activation: role of p38 MAP kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Role of cell signaling in B[a]P-induced apoptosis: characterization of unspecific effects of cell signaling inhibitors and apoptotic effects of B[a]P metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Benzo[a]pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Effects of anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on human small airway epithelial cells and the protective effects of myo-inositol

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Persistent activation of ERK1/2 by lead acetate increases nucleotide excision repair synthesis and confers anti-cytotoxicity and anti-mutagenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Cellular localization of human Rad51C and regulation of ubiquitin-mediated proteolysis of Rad51

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

ZD1839 ('Iressa') as an anticancer agent

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Targeted disruption of the Rad51 gene leads to lethality in embryonic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

RAD51 is involved in repair of damage associated with DNA replication in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Elevated recombination in immortal human cells is mediated by HsRAD51 recombinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.02.013

7 January 2021

Identifiers

10.1016/J.YEXCR.2008.02.013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377894%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39996855&oldid=1975650386"